Lupus clinical trials in Ohio
11 studies for Lupus are looking for participants at sites in Ohio.
Cities in Ohio
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Paramount Medical Research & Consulting, Middleburg Heights
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07438496Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Paramount Medical Research and Consulting, Middleburg Heights
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Sep 17, 2026 · NCT07409181An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Cincinnati
- Research Site, Cleveland
- Research Site, Columbus
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 10, 2026 · NCT05835310A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- MetroHealth Medical Center, Cleveland
- The Metro Health System Main Campus, Cleveland
- Cleveland Clinic Foundation, Cleveland
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 21, 2026 · NCT06570798Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Cleveland Clinic Foundation, Cleveland
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Paramount Med Rsrch and Consult LLC, Middleburg Heights
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Jul 8, 2026 · NCT06133972A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Columbus
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jun 22, 2026 · NCT06576271A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The MetroHealth System, Cleveland
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
- Nationwide Children's, Columbus
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 3, 2025 · NCT06340750From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.